A dietary intervention with functional foods reduces metabolic endotoxaemia and attenuates biochemical abnormalities by modifying faecal microbiota in people with type 2 diabetes

Diabetes & Metabolism - Tập 45 Số 2 - Trang 122-131 - 2019
Isabel Vera1,2, Mónica Sánchez‐Tapia1, Lilia G. Noriega1, Omar Granados‐Portillo1, Martha Guevara‐Cruz1, Adriana Flores‐López1, Azalia Ávila-Nava1, María Luz Fernández3, Armando R. Tovar1, Nimbe Torres1
1Departamento de Fisiología de la Nutrición, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, 14080 Ciudad de México, Mexico
2Facultad de Medicina, Programa de Doctorado en Ciencias Médicas, Odontológicas y de la Salud, Universidad Nacional Autónoma de México, 04510 CDMX, Mexico
3Department of Nutritional Sciences, University of Connecticut, Storrs, CT USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Wild, 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047

Mahendran, 2013, Glycerol and fatty acids in serum predict the development of hyperglycemia and type 2 diabetes in Finnish men, Diabetes Care, 36, 3732, 10.2337/dc13-0800

Evans, 2003, Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction?, Diabetes, 52, 1, 10.2337/diabetes.52.1.1

Thursby, 2017, Introduction to the human gut microbiota, Biochem J, 474, 1823, 10.1042/BCJ20160510

Flint, 2012, Microbial degradation of complex carbohydrates in the gut, Gut Microbes, 3, 289, 10.4161/gmic.19897

Cani, 2007, Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes, 56, 1761, 10.2337/db06-1491

Allin, 2015, Mechanisms in endocrinology: Gut microbiota in patients with type 2 diabetes mellitus, Eur J Endocrinol, 172, R167, 10.1530/EJE-14-0874

Tang, 2017, Increased trimethylamine n-oxide portends high mortality risk independent of glycemic control in patients with type 2 diabetes mellitus, Clin Chem, 63, 297, 10.1373/clinchem.2016.263640

Pedersen, 2016, Human gut microbes impact host serum metabolome and insulin sensitivity, Nature, 535, 376, 10.1038/nature18646

1998, Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults – The evidence report. National Institutes of Health, Obes Res, 6, 51S

Forslund, 2015, Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota, Nature, 528, 262, 10.1038/nature15766

van der Hulst, 1993, Glutamine and the preservation of gut integrity, Lancet, 341, 1363, 10.1016/0140-6736(93)90939-E

Achamrah, 2017, Glutamine and the regulation of intestinal permeability: from bench to bedside, Curr Opin Clin Nutr Metab Care, 20, 86, 10.1097/MCO.0000000000000339

Inzucchi, 2012, Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), Diabetes Care, 35, 1364, 10.2337/dc12-0413

Gomes, 2014, Gut microbiota, probiotics and diabetes, Nutr J, 13, 60, 10.1186/1475-2891-13-60

Wexler, 2007, Bacteroides: the good, the bad, and the nitty-gritty, Clin Microbiol Rev, 20, 593, 10.1128/CMR.00008-07

Whiting, 2011, IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030, Diabetes Res Clin Pract, 311, 10.1016/j.diabres.2011.10.029

Vilsboll, 2002, Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients, Diabetologia, 45, 1111, 10.1007/s00125-002-0878-6

Goralska, 2018, Pro-inflammatory gene expression profile in obese adults with high plasma GIP levels, Int J Obes (Lond), 42, 826, 10.1038/ijo.2017.305

Getty-Kaushik, 2006, Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification, Obesity (Silver Spring), 14, 1124, 10.1038/oby.2006.129

Timper, 2013, Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes, Am J Physiol Endocrinol Metab, 304, E1, 10.1152/ajpendo.00100.2012

Boden, 2002, Free fatty acids in obesity and type 2 diabetes: defining their role in the development of insulin resistance and beta-cell dysfunction, Eur J Clin Invest, 323, 14, 10.1046/j.1365-2362.32.s3.3.x

Guevara-Cruz, 2010, Increase in HDL-C concentration by a dietary portfolio with soy protein and soluble fiber is associated with the presence of the ABCA1R230C variant in hyperlipidemic Mexican subjects, Mol Genet Metab, 101, 268, 10.1016/j.ymgme.2010.08.007

Wilson, 2007, Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study, Arch Intern Med, 167, 1068, 10.1001/archinte.167.10.1068

Boutagy, 2016, Metabolic endotoxemia with obesity: Is it real and is it relevant?, Biochimie, 124, 11, 10.1016/j.biochi.2015.06.020

Nighot, 2017, Lipopolysaccharide-induced increase in intestinal epithelial tight permeability is mediated by toll-like receptor 4/myeloid differentiation primary response 88 (MyD88) activation of myosin light chain kinase expression, Am J Pathol, 187, 2698, 10.1016/j.ajpath.2017.08.005

Delzenne, 2015, Gut microorganisms as promising targets for the management of type 2 diabetes, Diabetologia, 58, 2206, 10.1007/s00125-015-3712-7

Serralde-Zuniga, 2014, Omental adipose tissue gene expression, gene variants, branched-chain amino acids, and their relationship with metabolic syndrome and insulin resistance in humans, Genes Nutr, 9, 431, 10.1007/s12263-014-0431-5

Li, 2009, Glutamine deprivation alters intestinal tight junctions via a PI3-K/Akt mediated pathway in Caco-2 cells, J Nutr, 139, 710, 10.3945/jn.108.101485

Cabreiro, 2016, Metformin joins forces with microbes, Cell Host Microbe, 19, 1, 10.1016/j.chom.2015.12.012

Qin, 2012, A metagenome-wide association study of gut microbiota in type 2 diabetes, Nature, 490, 55, 10.1038/nature11450

Wang, 2011, Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease, Nature, 472, 57, 10.1038/nature09922

Shan, 2017, Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes, Am J Clin Nutr, 106, 888, 10.3945/ajcn.117.157107

Koeth, 2013, Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis, Nat Med, 19, 576, 10.1038/nm.3145

Tuso, 2015, A plant-based diet, atherogenesis, and coronary artery disease prevention, Perm J, 19, 62, 10.7812/TPP/14-036

Jardine, 2016, Nutrition considerations for microbiota health in diabetes., Diabetes Spectr, 29, 238, 10.2337/ds16-0003

Vinke, 2017, The role of supplemental complex dietary carbohydrates and gut microbiota in promoting cardiometabolic and immunological health in obesity: lessons from healthy non-obese individuals, Front Nutr, 4, 34, 10.3389/fnut.2017.00034

Ramnani, 2015, A randomised, double-blind, cross-over study investigating the prebiotic effect of agave fructans in healthy human subjects, J Nutr Sci, 4, e10, 10.1017/jns.2014.68

Lopez-Palacios, 2016, Rheological flow behavior of structural polysaccharides from edible tender cladodes of wild, semidomesticated and cultivated ‘Nopal’ (Opuntia) of Mexican highlands, Plant Foods Hum Nutr, 71, 388, 10.1007/s11130-016-0573-2

Sanchez-Tapia, 2017, Nopal (Opuntia ficus indica) protects from metabolic endotoxemia by modifying gut microbiota in obese rats fed high fat/sucrose diet, Sci Rep, 7, 4716, 10.1038/s41598-017-05096-4

Lopez-Romero, 2014, The effect of nopal (Opuntia ficus indica) on postprandial blood glucose, incretins, and antioxidant activity in Mexican patients with type 2 diabetes after consumption of two different composition breakfasts, J Acad Nutr Diet, 114, 1811, 10.1016/j.jand.2014.06.352